| Date | Time | Source | Headline | Symbol | Company |
| 10/16/2012 | 8:00AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 10/16/2012 | 7:00AM | PR Newswire (US) | MAP Pharmaceuticals Resubmits New Drug Application to FDA for LEVADEX® Orally Inhaled Migraine Drug | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/29/2012 | 5:24PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/29/2012 | 5:00PM | PR Newswire (US) | MAP Pharmaceuticals, Inc. Announces Full Exercise of Underwriter's Option to Purchase Additional Shares of Common Stock | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/09/2012 | 7:00AM | PR Newswire (US) | MAP Pharmaceuticals to Present at Upcoming Investor Conferences | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/02/2012 | 6:03AM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/01/2012 | 9:48AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/01/2012 | 9:36AM | Dow Jones News | US HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/01/2012 | 9:05AM | PR Newswire (US) | MAP Pharmaceuticals, Inc. Prices Public Offering of Common Stock | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/01/2012 | 8:32AM | Edgar (US Regulatory) | Registration of Additional Securities (up to 20%) (S-3MEF) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/01/2012 | 6:58AM | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 07/31/2012 | 4:27PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 07/31/2012 | 4:08PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 07/31/2012 | 4:02PM | PR Newswire (US) | MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 07/27/2012 | 6:02AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 07/24/2012 | 8:04AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 07/24/2012 | 7:00AM | PR Newswire (US) | MAP Pharmaceuticals Reports Second Quarter of 2012 Financial Results | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 06/25/2012 | 1:16PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 06/25/2012 | 8:07AM | Dow Jones News | MAP Pharmaceuticals to Resubmit Application for Migraine Treatment This Year | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 06/25/2012 | 7:00AM | PR Newswire (US) | MAP Pharmaceuticals Provides Update Following Meeting with FDA for LEVADEX® (dihydroergotamine) New Drug Application | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 06/21/2012 | 4:05PM | PR Newswire (US) | MAP Pharmaceuticals to Present Data on LEVADEX® at the 54th Annual Scientific Meeting of the American Headache Society | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 06/08/2012 | 7:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/21/2012 | 4:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/21/2012 | 4:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/21/2012 | 4:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/21/2012 | 4:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/18/2012 | 5:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/18/2012 | 4:05PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/09/2012 | 5:06PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/08/2012 | 5:17PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |